MedTrace Logo

Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

NCT06304038 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5483

Last updated 2024-03-12

No results posted yet for this study

Summary

Flu vaccination, as well as being effective to prevent seasonal influenza, decreases staff illness and absenteeism and reduces costs resulting from loss of productivity. Despite the effectiveness of flu vaccination, the seasonal coverage among healthcare workers is usually low. The aim of this retrospective observational study is to analyze the vaccination coverage rate among all employees (healthcare workers and administrative staff) of a large teaching hospital in Rome during the 2017-2018 influenza season, to perform a cost-consequence analysis of influenza vaccination (by evaluating the absenteeism due to illness in the epidemic period), and to assess the impact of vaccination in terms of both costs and sick days.

Conditions

  • Influenza Vaccine
  • Cost-Benefit Analysis

Interventions

DRUG

Flu Vaccine

Administration of quadrivalent split inactivated non-adjuvanted flu vaccine Fluarix Tetra

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-16
Primary Completion
2018-04-29
Completion
2019-11-14

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06304038 on ClinicalTrials.gov